title: Head and neck cancers, the neglected malignancies: present and future treatment strategies.
abstract: Head and neck cancers are the most prevalent cancers in Asia and result in 50% of deaths due to all cancers in that region. However, treatment regimen has not changed in the past two decades and there are no specific drugs for this cancer. As a result of this, treatment outcomes remain poor. Furthermore, there are no new breakthrough therapies on the horizon, in part, due to low commercial interest in these cancers. What is needed is new thinking, which combines targeted and risk mitigation approaches to develop novel drugs. This editorial will focus on summarising the present approaches to treatment and propose new targets for these cancers.
authors: University of Hyderabad Campus, Dr. Reddy's Institute of Life Sciences , Gachibowli, Hyderabad , India.
authors: Pushkar
authors: P
authors: Kulkarni
authors: Uday
authors: U
authors: Saxena
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D055808:Drug Discovery / Q000639:trends*; D005544:Forecasting; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents